Genomictree Inc. (KOSDAQ:228760)

South Korea flag South Korea · Delayed Price · Currency is KRW
12,030
+30 (0.25%)
Jun 27, 2025, 3:30 PM KST
-45.57%
Market Cap 288.77B
Revenue (ttm) 2.39B
Net Income (ttm) -10.50B
Shares Out 24.00M
EPS (ttm) -432.67
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 282,723
Average Volume 124,067
Open 11,950
Previous Close 12,000
Day's Range 11,390 - 12,260
52-Week Range 11,390 - 25,100
Beta 0.05
RSI 36.99
Earnings Date Aug 12, 2025

About Genomictree

Genomictree Inc., a biomarker-based molecular diagnostics company, develops and commercializes molecular diagnostic products for the detection of cancer and various infectious diseases. The company offers EarlyTect C, a screening method for early diagnosis of colorectal cancer; EarlyTect L for detection of epigenetic markers associated with lung cancer in pulmonary nodule patients; and EarlyTect B for detection of genetic and epigenetic markers associated with bladder cancer in hematuria patients. It also provides AccuraDTect SARS-CoV-2 RT-qPCR... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2000
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 228760
Full Company Profile

Financial Performance

In 2024, Genomictree's revenue was 2.36 billion, a decrease of -30.89% compared to the previous year's 3.42 billion. Losses were -10.24 billion, 17.0% more than in 2023.

Financial Statements

News

There is no news available yet.